Table 3.
Assessment | Pre-treatment | Treatment | Follow-up | |||
Pre-registration* | Baseline † | Post SBRT‡ | Every 6 months§ | 24, 60 months§ | ||
Informed consent | ✓ | |||||
Eligibility assessment | ✓ | |||||
Staging investigations¶ | ✓ | |||||
Clinical examination | ✓ | ✓ | ✓ | |||
Adverse event | ✓ | ✓ | ✓ | ✓ | ||
PSA | ✓ | ✓ | ✓ | |||
PRO EPIC 26+/-IIEF 25 | ✓ | ✓ | ✓ |
*To be done within 60 days of registration.
†To be done no more than 2 weeks post-registration and within 4 weeks of starting treatment.
‡To be performed between 6 weeks post-SBRT treatment completion.
§From commencement of androgen deprivation therapy.
¶Note that PSMA-PET is mandated for high-risk patients. Whole body bone scan with CT or MRI of the pelvis ± abdomen are acceptable for unfavourable intermediate risk patients.
EPIC, Expanded Prostate Cancer Index Composite; PSA, prostate-specific antigen; SBRT, stereotactic body radiotherapy.